Atherosclerosis (journal)
Atherosclerosis is a medical journal that focuses on the study of atherosclerosis, a disease in which plaque builds up inside your arteries. The journal publishes original research articles, reviews, and editorials on all aspects of atherosclerosis, including its pathogenesis, epidemiology, clinical diagnosis, treatment, and prevention.
Overview
The Atherosclerosis journal was first published in 1969 and is currently published by Elsevier. The journal is affiliated with the European Atherosclerosis Society and the International Atherosclerosis Society. It is indexed in the PubMed database and the Science Citation Index. The journal's impact factor for 2019 was 4.25.
Scope
The Atherosclerosis journal covers a wide range of topics related to atherosclerosis. These include, but are not limited to, the molecular biology of atherosclerosis, genetic and environmental risk factors, the role of lipids and lipoproteins, inflammation, immunology, cell biology, pharmacology, endocrinology, nutrition, surgery, and cardiology.
Editorial Board
The Atherosclerosis journal's editorial board is composed of leading experts in the field of atherosclerosis from around the world. The current editor-in-chief is Professor John J.P. Kastelein from the University of Amsterdam, The Netherlands.
Submission and Review Process
The Atherosclerosis journal follows a rigorous peer review process to ensure the quality and integrity of the research it publishes. Authors are encouraged to submit their manuscripts online through the journal's submission system. The submitted manuscripts are then reviewed by at least two independent reviewers who are experts in the field.
Access
The Atherosclerosis journal offers both subscription-based and open access options for readers. The journal's content is available online through the publisher's website and other digital platforms.
- Atherosclerosis (journal).gif
Atherosclerosis (journal)
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD